Recursion Pharmaceuticals-a Earnings logo

RXRX

Recursion Pharmaceuticals-a Earnings

$5.41

Earnings Summary

Revenue
$4.51Mn
Net Profits
$-178.91Mn
Net Profit Margins
-3965.99%
Highlights
Revenue:

Recursion Pharmaceuticals-a’s revenue fell -58.58% since last year same period to $4.51Mn in the Q4 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated -82.7% fall in its revenue since last 3-months.

Net Profits:

Recursion Pharmaceuticals-a’s net profit fell -92.38% since last year same period to $-178.91Mn in the Q4 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated -86.99% fall in its net profits since last 3-months.

Net Profit Margins:

Recursion Pharmaceuticals-a’s net profit margin fell -364.47% since last year same period to -3965.99% in the Q4 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated -981.17% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Recursion Pharmaceuticals-a post its latest quarter earnings
EPS Estimate Current Quarter
-0.42
EPS Estimate Current Year
-0.42
Highlights
EPS Estimate Current Quarter:

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current quarter stand at -0.42 - a -19.09% fall from last quarter’s estimates.

EPS Estimate Current Year:

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current year stand at -0.42.

Key Ratios

Key ratios of the Recursion Pharmaceuticals-a post its Q4 2024 earnings
Earning Per Share (EPS)
-0.53
Return on Assets (ROA)
-0.28
Return on Equity (ROE)
-0.62
Highlights
Earning Per Share (EPS):

Recursion Pharmaceuticals-a’s earning per share (EPS) fell -26.19% since last year same period to -0.53 in the Q4 2024. This indicates that the Recursion Pharmaceuticals-a has generated -26.19% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Recursion Pharmaceuticals-a’s return on assets (ROA) stands at -0.28.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Recursion Pharmaceuticals-a’s return on equity (ROE) stands at -0.62.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-09
-0.42
-0.39
7.14%
2024-08-08
-0.4
-0.4
0%
2025-02-28
-0.42
-0.53
-27.16%
2024-11-06
-0.35
-0.34
2.86%

Discover More Earning Stocks in Services Sector